National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 28866-28867 [2017-13220]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
28866
Federal Register / Vol. 82, No. 121 / Monday, June 26, 2017 / Notices
Court of Federal Claims No: 17–0660V
55. Ethel Lynn Munn, Norfolk, Virginia,
Court of Federal Claims No: 17–0662V
56. Robert Meli, Ocean City, New Jersey,
Court of Federal Claims No: 17–0666V
57. John Sheridan, Phoenix, Arizona, Court
of Federal Claims No: 17–0669V
58. Christine Pearson, Warrenton, Virginia,
Court of Federal Claims No: 17–0670V
59. Shannon Finch, Riverside, California,
Court of Federal Claims No: 17–0675V
60. Elizabeth Turner, Sacramento, California,
Court of Federal Claims No: 17–0678V
61. Cynthia A. Marcinik, Latrobe,
Pennsylvania, Court of Federal Claims
No: 17–0680V
62. Kimberly R. Koebler, Pittsburgh,
Pennsylvania, Court of Federal Claims
No: 17–0681V
63. Tanitha Jackson on behalf of D.E.,
Albany, Georgia, Court of Federal Claims
No: 17–0682V
64. Kimberly Roberts, Torrance, California,
Court of Federal Claims No: 17–0683V
65. Billy Dean Peel, Martinez, Georgia, Court
of Federal Claims No: 17–0684V
66. Kristie McClure, Murphy, North Carolina,
Court of Federal Claims No: 17–0687V
67. Anita Burgess, Denton, Texas, Court of
Federal Claims No: 17–0688V
68. Victor Walker, Juneau, Alaska, Court of
Federal Claims No: 17–0689V
69. Mona Ibrahim, Fargo, North Dakota,
Court of Federal Claims No: 17–0690V
70. Darlene Dinkel, Salina, Kansas, Court of
Federal Claims No: 17–0691V
71. Todd Rosenthal, Ft. Mill, South Carolina,
Court of Federal Claims No: 17–0693V
72. Victor Morales, Pembroke Pines, Florida,
Court of Federal Claims No: 17–0694V
73. Valerie Mulholland, Florence, Oregon,
Court of Federal Claims No: 17–0696V
74. Joseph L. Wheatley, Louisville, Kentucky,
Court of Federal Claims No: 17–0697V
75. Julius Vine, Glendale, California, Court of
Federal Claims No: 17–0698V
76. Nico Herron and Patience Turner on
behalf of Xavier Herron, Deceased, Palo
Alto, California, Court of Federal Claims
No: 17–0700V
77. Jeffery Graves, Dresher, Pennsylvania,
Court of Federal Claims No: 17–0701V
78. Christy Lynn Day on behalf of Reid
Thomas Englehart, Deceased, Baton
Rouge, Louisiana, Court of Federal
Claims No: 17–0702V
79. Jamie L. Pinelli, San Clemente, California,
Court of Federal Claims No: 17–0704V
80. Samuel Schrecengost, Clarion,
Pennsylvania, Court of Federal Claims
No: 17–0705V
81. Linda McDonald, Voorhees, New Jersey,
Court of Federal Claims No: 17–0706V
82. Willie Griffin, Dallas, Texas, Court of
Federal Claims No: 17–0707V
83. Carolyn Curtis, Waldorf, Maryland, Court
of Federal Claims No: 17–0708V
84. Jannie Owens, Knoxville, Tennessee,
Court of Federal Claims No: 17–0709V
85. Marc Dudash, Greensboro, North
Carolina, Court of Federal Claims No:
17–0710V
86. Jennifer Butterworth Lyons, Chicago,
Illinois, Court of Federal Claims No: 17–
0713V
87. Lynn Farag on behalf of Z.F., Roseland,
VerDate Sep<11>2014
17:04 Jun 23, 2017
Jkt 241001
New Jersey, Court of Federal Claims No:
17–0714V
88. Catherine W. Viega, Rochester, New York,
Court of Federal Claims No: 17–0715V
89. Iola Sykes, Sarasota, Florida, Court of
Federal Claims No: 17–0716V
90. Dennis Smalley, Washington, District of
Columbia, Court of Federal Claims No:
17–0717V
91. Lauren Jankowski on behalf of L.J.,
Englewood, New Jersey, Court of Federal
Claims No: 17–0718V
92. Marci Talley Banks, Greensboro, North
Carolina, Court of Federal Claims No:
17–0719V
93. Paula Burcham, Mankato, Minnesota,
Court of Federal Claims No: 17–0720V
94. Darlene Headding, Rancho Santa
Margarita, California, Court of Federal
Claims No: 17–0721V
95. Linda Chen on behalf of K.N., Boston,
Massachusetts, Court of Federal Claims
No: 17–0722V
96. Tina Reynolds, Beverly Hills, California,
Court of Federal Claims No: 17–0723V
[FR Doc. 2017–13314 Filed 6–23–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Pancreas-Related
Applications.
Date: July 14, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Digestive Disease
Research Core Centers.
Date: July 19, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Bladder Function
P01.
Date: July 21, 2017.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK17–501
Limited Competition: Revision Application
for the Human Islet Research Network
Coordinating Center (U01).
Date: July 24, 2017.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK16–005
Identification of Mechanisms Mediating the
Effects of Sleep on Diabetes-Related
Metabolism in Humans (R01).
Date: July 25, 2017.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
E:\FR\FM\26JNN1.SGM
26JNN1
Federal Register / Vol. 82, No. 121 / Monday, June 26, 2017 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 20, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13220 Filed 6–23–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Hepatology.
Date: July 11, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Drug Development and Xenobiotic
Disposition.
Date: July 13, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
VerDate Sep<11>2014
18:04 Jun 23, 2017
Jkt 241001
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
117: iKnow HIV Applications.
Date: July 18, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV and Related Research.
Date: July 18, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Multidisciplinary Studies of HIV and Viral
Hepatitis Co-Infection.
Date: July 19, 2017.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Host Defense and Vaccines.
Date: July 19, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review (CSR), National Institutes
of Health (NIH), 6701 Rockledge Dr, Room
4203, Bethesda, MD 20817, (301) 435–3566,
alok.mulky@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
28867
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 20, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13213 Filed 6–23–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Integrative Health Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; NCCIH Training and
Education Review Panel.
Date: July 19, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ashlee Tipton, PhD.,
Scientific Review Officer, Division of
Extramural Activities, National Center for
Complementary and Integrative Health, 6707
Democracy Boulevard, Room 401, Bethesda,
MD 20892, 301–451–3849, ashlee.tipton@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: June 20, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13215 Filed 6–23–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 82, Number 121 (Monday, June 26, 2017)]
[Notices]
[Pages 28866-28867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13220]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Pancreas-Related
Applications.
Date: July 14, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Digestive Disease
Research Core Centers.
Date: July 19, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Bladder Function P01.
Date: July 21, 2017.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, ryan.morris@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA DK17-501 Limited
Competition: Revision Application for the Human Islet Research
Network Coordinating Center (U01).
Date: July 24, 2017.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA DK16-005
Identification of Mechanisms Mediating the Effects of Sleep on
Diabetes-Related Metabolism in Humans (R01).
Date: July 25, 2017.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
[[Page 28867]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 20, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13220 Filed 6-23-17; 8:45 am]
BILLING CODE 4140-01-P
